🇺🇸 FDA
Pipeline program

NS2

NS2-02

Phase 2 small_molecule completed

Quick answer

NS2 for Non-infectious Anterior Uveitis is a Phase 2 program (small_molecule) at Aldeyra Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aldeyra Therapeutics
Indication
Non-infectious Anterior Uveitis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials